Susquehanna International Group
OMED

Susquehanna International Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Susquehanna International Group’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-59,700
Closed -$199K – 10347
2017
Q2 		$199K Sell
59,700
-6,600
-10% -$27.4K ﹤0.01% 8300
2017
Q1 		$611K Buy
66,300
+27,600
+71% +$242K ﹤0.01% 6129
2016
Q4 		$298K Sell
38,700
-1,500
-4% -$13.8K ﹤0.01% 7986
2016
Q3 		$459K Buy
40,200
+7,600
+23% +$88.5K ﹤0.01% 6222
2016
Q2 		$401K Sell
32,600
-8,500
-21% -$103K ﹤0.01% 6492
2016
Q1 		$416K Sell
41,100
-100
-0.2% -$1.17K ﹤0.01% 6720
2015
Q4 		$929K Sell
41,200
-37,800
-48% -$775K ﹤0.01% 5558
2015
Q3 		$1.31M Buy
79,000
+28,300
+56% +$567K ﹤0.01% 5136
2015
Q2 		$1.14M Buy
50,700
+26,000
+105% +$641K ﹤0.01% 5933
2015
Q1 		$637K Buy
+24,700
New +$626K ﹤0.01% 6656
2014
Q4 		– Sell
-12,000
Closed -$227K – 10675
2014
Q3 		$227K Buy
+12,000
New +$241K ﹤0.01% 8467

Susquehanna International Group's OMED Position: Q2 2019 in Review

Susquehanna International Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 14,993 shares — an estimated $16K sold.

Susquehanna International Group first reported a position in OMED in Q4 2014 and held it in 12 quarters. The position peaked at $810K in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

  • Susquehanna International Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 14,993 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $16K.
  • Susquehanna International Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 12 quarters.
  • Susquehanna International Group's OncoMed Pharmaceuticals, Inc. position peaked at $810K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.